Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

Exosens wins major order from the Czech Republic and shares rise

Exosens received a contract to supply about 17,000 image intensifier units to the armed forces of the Czech Republic (via Brolis) through 2032, causing the stock to gain today. Last week the European Investment Bank approved €140m in financing for R&D and industrial investments in night vision and imaging technologies. Exosens also secured a record order from a developer of autonomous air‑defense systems for digital imaging in interceptor drones, and analysts maintain a consensus "buy" rating with an average 12‑month price target well above the current price. Investors are watching the H1‑2026 results, expected in about a month, as the next catalyst. » More on de.investing.com
Plans to double production drive Exosens share higher

Exosens has announced it will double its production capacity for infrared cameras to meet rising global demand for digital imaging solutions for remote surveillance and drone defense. The announcement lifted the stock in Paris by about 5.9%. The company views the capacity increase as a sign of strong demand and potential revenue growth for its infrared camera products. » More on de.investing.com
Exosens increases Q1 revenue to EUR 122.6m and confirms annual forecast

Exosens reported Q1 revenue of EUR 122.6m (+19.7% year‑on‑year). The Detection and Imaging division grew to EUR 34.6m (+44.5%) and the adjusted gross margin rose to EUR 63.5m (+20.1%). The company confirms its forecast for 2026 and expects positive effects from capacity expansions in Europe and the US starting in the second half of the year. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Exosens SA has already paid €0.30 in dividends. The last payout was in May.

Financials

In the last quarter, Exosens SA had revenue of €253.1m and net profit of €15.3m

(EUR)	June 2026	YoY
Revenue	253.1m	-
Gross profit	32.7m	-
Net profit	15.3m	-
EBITDA	77.6m	-

Fundamentals

Metric	Value
Market capitalization	€2.76bn
Number of shares	50.91m
52-week high/low	€74.00 - €40.00
Dividend yield	0.54%
Dividends TTM	€0.30
Beta	0.82
P/E ratio	92.03
PEG ratio	-1.81
P/B ratio	6.13
P/S ratio	5.56

Company profile

Exosens engages in the development, manufacture, and sale of electro-optical technologies in the fields of amplification, and detection and imaging in France, rest of Europe, North America, Asia, Oceania, Africa, and internationally. It offers image intensifier tubes; ultra violet, short and long wave infrared, visible - near infrared, and mid wave infrared cameras, as well as enhanced vision equipment; ion and electron, scintillation, and single photon detection products; x-ray components, neutronic imaging products, and image intensifiers for scientific applications; and gamma and neutron detectors, and mineral insulated extensions. The company also provides power tubes and microwave devices; and methane airborne detection solutions. It operates under the Photonis, Xenics, Telops, and El-Mul brand names. The company serves defense and surveillance, industrial research and control, life science and environment, and nuclear markets. The company was founded in 1937 and is based in Mérignac, France. Exosens operates as a subsidiary of HLD Europe S.C.A.